References
1. Carrington PR, Sanusi ID, Winder PR, Turk LL, Jones C, Millikan LE. Scleredema adultorum. International journal of dermatology . 1984;23(8):514-522. doi: 10.1111/j.1365-4362.1984.tb04202.x.
2. Miguel D, Schliemann S, Elsner P. Treatment of Scleroedema Adultorum Buschke: A Systematic Review. Acta dermato-venereologica . 2018;98(3):305-309. doi: 10.2340/00015555-2846.
3. Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, Damevska K, Girolomoni G, André J, Perrot JL, Kempf W, Cavelier-Balloy B. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. Journal of the European Academy of Dermatology and Venereology : JEADV. 2015;29(12):2399-2404. doi: 10.1111/jdv.13272.
4. Wu EB, Fuller LC, Hughes RA, Chambers JB. Images in cardiovascular medicine: Rare cause of cardiomyopathy. Circulation . 2001;103(23):2867. doi: 10.1161/hc2301.091931.
5. Nakatsuji M, Ishimaru N, Ohnishi J, Mizuki S, Kanzawa Y, Kawano K, Nakajima T, Kuroda M, Sano N, Kinami S. Scleredema with biopsy-confirmed cardiomyopathy: A case report. Journal of scleroderma and related disorders . 2021;6(3):311-315. doi: 10.1177/23971983211013977.
6. Haustein UF. Scleroderma and pseudo-scleroderma: uncommon presentations. Clinics in dermatology . 2005;23(5):480-490. doi: 10.1016/j.clindermatol.2005.01.019.
7. Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, Doria A. Scleroderma-like disorders. Autoimmunity reviews . 2008;7(4):331-339. doi: 10.1016/j.autrev.2007.12.004. doi: 10.1016/j.autrev.2007.12.004.
8. Alhunaif SA, Alsarheed A, Almutairi R, Almutairi G. Atypical Case of Combined Types I and II Scleredema Mimicking Morphea on Histopathology.Cureus . 2023;15(1):e34077. doi: 10.7759/cureus.34077.
9. Gandolfi A, Pontara A, Di Terlizzi G, Rizzo N, Nicoletti R, Scavini M, Galimberti G, Bosi E. Improvement in clinical symptoms of scleredema diabeticorum by frequency-modulated electromagnetic neural stimulation: a case report. Diabetes care . 2014;37(11):e233-234. doi: 10.2337/dc14-0730.
10. Turchin I, Adams SP, Enta T. Dermacase. Scleredema adultorum, or Bushke disease. Canadian family physician Medecin de famille canadien . 2003;49:1089, 1093.
11. Muhaidat J, Al-Qarqaz F, Alshiyab D. Unilateral Linear Induration of the Skin: A Case Report of an Unusual Presentation of Scleredema.The Journal of clinical and aesthetic dermatology . 2020;13(12):E53-e55.
12. Rimon D, Lurie M, Storch S, Halon D, Eisenkraft S, Laor A, Cohen L. Cardiomyopathy and multiple myeloma. Complications of scleredema adultorum. Archives of internal medicine . 1988;148(3):551-553.
13. Johnson ML, Ikram H. Scleroedema of Buschke. An uncommon cause of cardiomyopathy. British heart journal . 1970;32(5):720-722. doi: 10.1136/hrt.32.5.720.
14. Vallee BL. Scleredema: a systemic disease. The New England journal of medicine . 1946;235(7):207-213. doi: 10.1056/nejm194608152350701.
15. Leinwand I. Generalized scleroderma; report with autopsy findings.Annals of internal medicine . 1951;34(1):226-238. doi: 10.7326/0003-4819-34-1-226.
16. Ehsan M, Kelly M, Hooper C, Yavari A, Beglov J, Bellahcene M, Ghataorhe K, Poloni G, Goel A, Kyriakou T, Fleischanderl K, Ehler E, Makeyev E, Lange S, Ashrafian H, Redwood C, Davies B, Watkins H, Gehmlich K. Mutant Muscle LIM Protein C58G causes cardiomyopathy through protein depletion. Journal of molecular and cellular cardiology . 2018;121:287-296. doi: 10.1016/j.yjmcc.2018.07.248.
17. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Molecular genetics and metabolism . 2006;88(1):78-85. doi: 10.1016/j.ymgme.2005.10.008.
18. Ingles J, Goldstein J, Thaxton C, Caleshu C, Corty EW, Crowley SB, Dougherty K, Harrison SM, McGlaughon J, Milko LV, Morales A, Seifert BA, Strande N, Thomson K, Peter van Tintelen J, Wallace K, Walsh R, Wells Q, Whiffin N, Witkowski L, Semsarian C, Ware JS, Hershberger RE, Funke B. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.Circulation Genomic and precision medicine . 2019;12(2):e002460. doi: 10.1161/CIRCGEN.119.002460.
19. Salazar-Mendiguchía J, Barriales-Villa R, Lopes LR, Ochoa JP, Rodríguez-Vilela A, Palomino-Doza J, Larrañaga-Moreira JM, Cicerchia M, Cárdenas-Reyes I, García-Giustiniani D, Brögger N, Fernández G, García S, Santiago L, Vélez P, Ortiz-Genga M, Elliott PM, Monserrat L. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals. European journal of medical genetics . 2020;63(12):104079. doi: 10.1016/j.ejmg.2020.104079.